Laurence Laigle

477 total citations
8 papers, 61 citations indexed

About

Laurence Laigle is a scholar working on Rheumatology, Immunology and Oncology. According to data from OpenAlex, Laurence Laigle has authored 8 papers receiving a total of 61 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Rheumatology, 3 papers in Immunology and 2 papers in Oncology. Recurrent topics in Laurence Laigle's work include Systemic Lupus Erythematosus Research (4 papers), T-cell and B-cell Immunology (2 papers) and Chemokine receptors and signaling (2 papers). Laurence Laigle is often cited by papers focused on Systemic Lupus Erythematosus Research (4 papers), T-cell and B-cell Immunology (2 papers) and Chemokine receptors and signaling (2 papers). Laurence Laigle collaborates with scholars based in France, Spain and Greece. Laurence Laigle's co-authors include Philippe Moingeon, Frédéric De Ceuninck, Loubna Chadli, Mickaël Guedj, Antoine Hamon, Sandra Hubert, Céline Lefèbvre, Sylvie Bretin, Johan Frostegård and Chris Chamberlain and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Annals of the Rheumatic Diseases.

In The Last Decade

Laurence Laigle

8 papers receiving 59 citations

Peers

Laurence Laigle

MB

IMMUN

RHEUM

CTM

ONCOL

Emilia Roy‐Vallejo Spain

Zhongnan Qin United States

Jacob T. Mitchell United States

Charlotte Thompson United Kingdom

Erin Moore United States

Tejas Shah United Kingdom

Jimeng Xue China

Zoe Adhya United Kingdom

Elisha Stefanski United States

Craig D. Scoville United States

Emilia Roy‐Vallejo Spain

Laurence Laigle

25 ×0.9

MB

17 ×0.7

IMMUN

6 ×0.3

RHEUM

2 ×0.2

CTM

9 ×1.1

ONCOL

Citations per year, relative to Laurence Laigle Laurence Laigle (= 1×) peers Emilia Roy‐Vallejo

Countries citing papers authored by Laurence Laigle

Since Specialization

Citations

This map shows the geographic impact of Laurence Laigle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laurence Laigle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laurence Laigle more than expected).

Fields of papers citing papers by Laurence Laigle

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laurence Laigle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laurence Laigle. The network helps show where Laurence Laigle may publish in the future.

Co-authorship network of co-authors of Laurence Laigle

This figure shows the co-authorship network connecting the top 25 collaborators of Laurence Laigle. A scholar is included among the top collaborators of Laurence Laigle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laurence Laigle. Laurence Laigle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Hurez, Vincent, R. C. Myers, Robert Sheehan, et al.. (2025). Virtual patients inspired by multiomics predict the efficacy of an anti-IFNα mAb in cutaneous lupus. iScience. 28(2). 111754–111754. 1 indexed citations

2.

Hémon, Patrice, Christelle Le Dantec, Loukas Chatzis, et al.. (2023). High-content multimodal analysis supports the IL-7/IL-7 receptor axis as a relevant therapeutic target in primary Sjögren's syndrome. Journal of Autoimmunity. 149. 103147–103147. 2 indexed citations

3.

Laigle, Laurence, Loubna Chadli, & Philippe Moingeon. (2023). Biomarker-driven development of new therapies for autoimmune diseases: current status and future promises. Expert Review of Clinical Immunology. 19(3). 305–314. 13 indexed citations

4.

Guedj, Mickaël, Antoine Hamon, Sandra Hubert, et al.. (2022). Industrializing AI-powered drug discovery: lessons learned from the Patrimony computing platform. Expert Opinion on Drug Discovery. 17(8). 815–824. 10 indexed citations

5.

Hamon, Antoine, et al.. (2021). Network-based repurposing identifies anti-alarmins as drug candidates to control severe lung inflammation in COVID-19. PLoS ONE. 16(7). e0254374–e0254374. 11 indexed citations

6.

Kaplon, Hélène, et al.. (2021). Applications of transcriptomics in support of drug development for osteoarthritis. SHILAP Revista de lepidopterología. 3(4). 100221–100221. 1 indexed citations

7.

Ceuninck, Frédéric De, et al.. (2021). IFN-α: A key therapeutic target for multiple autoimmune rheumatic diseases. Drug Discovery Today. 26(10). 2465–2473. 22 indexed citations

8.

Laigle, Laurence, Lorenzo Beretta, Jacqueline Marovac, et al.. (2018). AB1372 Towards reforming the taxonomy of human disease: the precisesads cross sectional study. Annals of the Rheumatic Diseases. 77. 1771–1772. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact